Status:
COMPLETED
Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders
Lead Sponsor:
Virginia Polytechnic Institute and State University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Autistic Disorder
Child Development Disorders, Pervasive
Eligibility:
All Genders
12-17 years
Phase:
PHASE1
Brief Summary
This study will develop and test a treatment aimed at reducing anxiety in social situations for children and adolescents with autism spectrum disorders.
Detailed Description
Autism spectrum disorders (ASDs) are developmental disorders with similar features, including problems communicating, problems interacting socially, and the presence of routines or repetitive behavior...
Eligibility Criteria
Inclusion
- Diagnosis of autism, Asperger's syndrome, or pervasive developmental disorders not otherwise specified (PDD-NOS), as determined by clinical interview and supported by the Autism Diagnostic Interview-Revised (ADI-R) and Autism Diagnostic Observation Schedule (ADOS)
- Has completed assessment of brief verbal intelligence quotient (IQ), with a score of 70 or higher on the Weschler Abbreviated Scale of Intelligence (WASI)
- Symptoms of anxiety, defined as a clinical severity rating of 4 or higher on one of the following sections of the Anxiety Disorders Interview Schedule for Children (ADIS-C) and parents (ADIS-P): generalized anxiety disorder (GAD), social phobia, specific phobia, agoraphobia, or separation anxiety disorder
- If on psychiatric medication, on stable dose for 4 weeks prior to baseline assessment with no planned changes to medication for anxiety
Exclusion
- Psychopathology that warrants a different type of immediate clinical care
- Severe aggression, as determined by clinical judgment
- Mental retardation, as reported by parents or in previous psychoeducational testing supplied by parents
- Child and family currently in therapy
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00926471
Start Date
September 1 2008
End Date
January 1 2013
Last Update
November 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Polytechnic Institute and State University
Blacksburg, Virginia, United States, 24061